{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:14:25Z","timestamp":1778739265673,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.addbeh.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T18:51:06Z","timestamp":1508352666000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack"],"prefix":"10.1016","volume":"77","author":[{"given":"F.","family":"Heidebrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2017.10.013_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1747-597X-9-46","article-title":"Association between methadone dose and concomitant cocaine use in methadone maintenance treatment: A register-based study","volume":"9","author":"Baumeister","year":"2014","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bcp.12051","article-title":"Pharmacological maintenance treatments of opiate addiction","volume":"77","author":"Bell","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/09595239996734","article-title":"Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment","volume":"18","author":"Best","year":"1999","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/09595230120058588","article-title":"Multiple drug use: Patterns and practices of heroin and crack use in a population of opiate addicts in treatment","volume":"20","author":"Beswick","year":"2001","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2010.05.014","article-title":"Methadone maintenance treatment: A protective factor for cocaine injection in a street-recruited cohort of heroin users","volume":"112","author":"Bravo","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00952990903108215","article-title":"Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials","volume":"35","author":"Castells","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1521-0391.2013.12032.x","article-title":"Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users","volume":"22","author":"Cunningham","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1521-0391.2011.00148.x","article-title":"A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers","volume":"20","author":"Dakwar","year":"2011","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2005.01.006","article-title":"Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS)","volume":"28","author":"Darke","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0050","author":"Department of Health (England) and the devolved administrations"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","article-title":"Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against","volume":"98","author":"Epstein","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1521-0391.2013.12074.x","article-title":"Predictive factors for relapse in patients on buprenorphine maintenance","volume":"23","author":"Ferri","year":"2014","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bcp.12031","article-title":"Long term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack?","volume":"77","author":"Garcia-Portilla","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/00952990.2013.842241","article-title":"Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder","volume":"40","author":"Griffin","year":"2014","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban equal access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use","volume":"85","author":"Hartel","year":"1995","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.drugalcdep.2013.02.030","article-title":"Association of cannabis use with opioid outcomes among opioid-dependent youth","volume":"132","author":"Hill","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0740-5472(90)90035-O","article-title":"Depressive symptoms during buprenorphine treatment of opioid abusers","volume":"7","author":"Kosten","year":"1990","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/ajp.154.9.1214","article-title":"Are supplementary services provided during methadone maintenance really cost-effective?","volume":"154","author":"Kraft","year":"1997","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: Review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"1\u20138","key":"10.1016\/j.addbeh.2017.10.013_bb0120","article-title":"Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial)","volume":"135","author":"Lions","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2466\/pr0.100.2.520-524","article-title":"Depression and cocaine dependence","volume":"100","author":"L\u00f3pez","year":"2007","journal-title":"Psychological Reports"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","article-title":"Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","volume":"13","author":"Marsch","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(09)61420-3","article-title":"Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study, for the National Drug Treatment Monitoring System Outcomes Study Group","volume":"374","author":"Marsden","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0140","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1360-0443.2008.02284.x","article-title":"Development of the treatment outcomes profile","volume":"103","author":"Marsden","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: A crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0155","author":"NICE"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0160","author":"NTA (National Treatment Agency for Substance Misuse)"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0165","author":"PHE (Public Health England)"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT Trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","article-title":"Psychiatric diagnoses of treatment-seeking cocaine abusers","volume":"48","author":"Rounsaville","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12954-016-0100-7","article-title":"Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study)","volume":"13","author":"Roux","year":"2016","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0185","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3109\/10826081003791932","article-title":"Effectiveness of therapies for heroin addiction in retaining patients in treatment: Results from the VEdeTTE study","volume":"45","author":"Salamina","year":"2010","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jfda.2013.09.037","article-title":"Medication-assisted treatment for opioid addiction: Methadone and buprenorphine","volume":"21","author":"Saxon","year":"2013","journal-title":"Journal of Food and Drug Analysis"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0195","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1360-0443.1996.918119711.x","article-title":"Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome","volume":"91","author":"Saxon","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0200","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0205","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimized oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomized trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2005.11.009","article-title":"One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)","volume":"83","author":"Teesson","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.8.1.1","article-title":"Opioid maintenance: A comparative review of pharmacological strategies","volume":"8","author":"White","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.addbeh.2017.10.013_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","article-title":"The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence","volume":"81","author":"Williamson","year":"2006","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317303842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317303842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T20:52:34Z","timestamp":1535316754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460317303842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"alternative-id":["S0306460317303842"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.10.013","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}